RG
RootPath Genomics develops a personalized T cell therapy platform utilizing molecular programming-based DNA fragment assembly technology to provide researchers with scalable access to long synthetic genes and their functional readouts. This approach addresses the need for efficient gene function interrogation in precision medicine, enabling faster and more accurate therapeutic development.
Updated 8 months ago
Funding
$68M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CINVSCVVYHFounders
Founder details are not available yet.
Product
Features
- RootPath Genomics develops a personalized T cell therapy platform utilizing molecular programming-based DNA fragment assembly technology to provide researchers with scalable access to long synthetic genes and their functional readouts. This approach addresses the need for efficient gene function interrogation in precision medicine, enabling faster and more accurate therapeutic development.